What are the practical issues with VKA and NOAC cardioversion?
VKA and NOAC cardioversion both have their own unique practical issues. VKA cardioversions typically require at least 3 weeks of pre-cardioversion anticoagulation, while NOAC cardioversions require either a loading dose of the specific NOAC agent or a reversal agent to be given prior to cardioversion. Additionally, VKA cardioversions are more likely to be associated with thromboembolic complications, while NOAC cardioversions can sometimes be complicated by recurrent bleeding due to inadequate reversal of anticoagulation. Finally, VKA cardioversions typically require more frequent monitoring than NOAC cardioversions.